Moderna's Spikevax vaccine has been fully approved for children with high-risk conditions, the first vaccine to do so.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

Science reported that the National Institutes of Health (NIH) director, Jay Bhattacharya, dismissed all members of the agency’s top external advisory body, the Advisory Committee to the Director (ACD) ...

CSIR-Centre for Cellular and Molecular Biology (CCMB) Atal Incubation Centre (AIC) is planning to go ahead with the next stage larger-scale trials of the indigenously developed mRNA vaccine technology ...

In just 3 years, the Influenza Vaccines Research and Development (R&D) Roadmap Initiative has demonstrated important ...

While people living in the lowest-income census tract quartile (Q1) lost more life expectancy than the highest-income group (Q4; eg, 4. vs 1.75 years in 2021), the gap between Q1 and Q4 in 2024 was ...

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

The Atal Incubation Centre (AIC) at CSIR-Centre for Cellular and Molecular Biology (CCMB) is progressing with larger-scale ...

Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...